EN
Disclaimer: The Analyst Recommendation and Tools & Analysis services and its content should not be construed as a solicitation to invest and/or trade. There are potential risks relating to investing and trading. You should always consider your trading objectives & risk capital, you should not trade with money that you cannot afford to lose. MARKETS.COM and their associates, do not guarantee the completeness, accuracy or timeliness of the information supplied, and they shall not be liable for any loss or damages, consequential or otherwise, which may arise from the use of such services and their content. Past performance is not indicative of future performance. All opinions, news, research, analysis, prices or other information is provided as general market commentary and not as investment advice and all potential results discussed are not guaranteed to be achieved.
Insights Trading News
Get the latest markets news from our financial experts. Discussing how economic developments, trade deals, company reports, and other events impact the markets, our insights give you unique insight into your trades.
Trading news is one of the best ways for you to stay informed about the markets you trade, so you never miss an opportunity.
Latest Insights
Thu, 30 April 2020
Shell sold, Lloyds crumples, markets look to future post Covid
Shares in Shell slumped 7% as it cut its dividend and reported net income in the first quarter almost halved. Whilst BP chose to absorb a $6bn rise in net debt to $51bn and gearing above 36x in order to preserve its precious dividend, Shell seems to be taking a more prudent approach in cutting its dividend for the first time since the 1940s. Arguably BP is better placed to weather the storm, but Shell is taking the more sensible course of action. Shell’s gearing ratio is down to around 28x, a more comfortable level for Ben van Beurden than it is for Bernard Looney. This poses a simple question for investors – can BP keep it up?
Wed, 29 April 2020
Markets jump on Gilead news
European stocks added to gains and US futures extended higher after a report indicated positive results from Gilead’s drug trials for treating Covid-19. Meanwhile, after some delay and an initial misprint we learned US GDP contracted 4.8% in the first quarter.
Wed, 29 April 2020
Barclays shares pop, SPX faces big hurdle with Fed, GDP ahead
Barclays CEO Jes Staley reckons that after Covid-19 the idea of sticking thousands of people in a building may be a thing of the past. I heartily agree. Working from home is clearly working rather well. Also, banks are no doubt looking at this and thinking they can cut costs by closing offices, call centres and branches. Nevertheless, it highlights how bosses and government have a very hard task in exiting lockdown. Moreover, what about the Pret or the pub that depends on lunch trade from the City workers filling up these offices every day? The impact on the economy will be permanent.
Tue, 28 April 2020
Fed and ECB previews
Chief market analyst Neil Wilson takes a look at what to expect from this week’s Federal Open Market Committee and European Central Bank monetary policy meetings.
Tue, 28 April 2020
HSBC & BP absorb the damage, oil plunges again
The S&P 500 rallied to close at its highest since March 10th as investors pin their hopes on states reopening in the coming days and weeks, but we’ve had a less impressive session overnight in Asia. European shares are a bit mixed today on a huge day for corporate earnings which are by and large showing up the huge damage being done to heavyweight stocks from Covid-19 and the collapse in oil prices. The FTSE 100 opened mildly lower but is holding the 5800 level. US futures have weakened along with oil, which is coming under intense selling pressure again.
Mon, 27 April 2020
Upbeat start for European equities
No Monday morning blues for equities after the Bank of Japan announced more stimulus and we’ve some good news from Italy at last and even Deutsche Bank has reported a profit. The BOJ laid down the gauntlet to the Federal Reserve and European Central Bank, who both meet later this week, by raising its package of support. The BOJ will now buy unlimited government bonds (JGBs), catching up with market expectations, and is increasing how much corporate and commercial paper it buys.
Sun, 26 April 2020
Week Ahead: Bumper week with FOMC, ECB, FAANGS & GDP
Your preview of the key events in the week to come, including interest rate decisions from the European Central Bank and Federal Open Market Committee, earnings from Apple, Alphabet, Amazon, Facebook, and Tesla, and Q1 growth data for the US and the Eurozone.
Fri, 24 April 2020
Stocks head lower after Gilead, EU disappointments
US stocks faded and European equity markets are broadly weaker following on reports Gilead’s Remdesivir drug isn’t what it was cracked up to be. It had been indications of early positive results for treating Covid-19 patients with the drug that sent markets up at the tail end of last week. We should note these are all leaked reports and the data is sketchy at best. What it shows is how the market is prepared to read into positive vaccine or anti-viral news with extreme optimism, setting the bar high for disappointment.
Thu, 23 April 2020
PMIs crash as social distancing looks set to last, European shares softer
Britain faces future of social distancing. The chief medical officer for England, Chris Witty, says some disruptive lockdown measures will remain in force for the rest of the year. Pubs and restaurants may not open until Christmas. If they can before, you only need to do the arithmetic and work out that a pub which could usually count on being chock full of a Friday night won’t do much business if everyone is forced to stand six feet apart. They will lose less money by staying shut. It’s increasingly looking like a total failure by the British government to implement the testing required to get the country moving. Lockdown measures cannot become normalised.
